CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
KPC Pharmaceuticals Inc Company Snapshot
KPC Pharmaceuticals Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares KPC Pharmaceuticals Inc with three other companies in this sector in China: JiangSu Bicon Pharmaceutical Listed Co (2017 sales of 5.37 billion Chinese Renmimbi [US$852.60 million] of which 46% was Pharmaceutical Intermediates), Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (5.69 billion Chinese Renmimbi [US$903.62 million] ), and Hubei Jumpcan Pharmaceutical Co Ltd (5.64 billion Chinese Renmimbi [US$896.12 million] of which 96% was Industrial).

Sales Analysis. KPC Pharmaceuticals Inc reported sales of 5.85 billion Chinese Renmimbi (US$929.52 million) for the year ending December of 2017. This represents an increase of 14.7% versus 2016, when the company's sales were 5.10 billion Chinese Renmimbi. Sales at KPC Pharmaceuticals Inc have increased during each of the previous five years (and since 2012, sales have increased a total of 94%). Sales of Daily Necessities saw an increase that was more than double the company's growth rate: sales were up 351.2% in 2017, from 956,636.43 Chinese Renmimbi to 4.32 million Chinese Renmimbi. KPC Pharmaceuticals Inc also saw significant increases in sales in Oral Agents (up 23.4% to 1.83 billion Chinese Renmimbi) and Injection (up 30.0% to 1.35 billion Chinese Renmimbi) and Medical Services (up 343.3% to 2.88 million Chinese Renmimbi) and Other (up 110.9% to 93.08 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
KPC Pharmaceuticals Inc
  Stock Performance Chart for KPC Pharmaceuticals Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 9.13
(Figures in Chinese Renmimbi)
1 Week -1.3%   13 Weeks 2.2%  
4 Weeks 0.2%   52 Weeks -23.4%  
 
KPC Pharmaceuticals Inc Key Data:
  Ticker: 600422 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 5,852,287,433
(Year Ending Jan 2018).
Employees: 4,469
  Currency: Chinese Renmimbi Market Cap: 7,177,984,974
  Fiscal Yr Ends: December Shares Outstanding: 786,197,697
  Share Type: A Gu Closely Held Shares: 349,423,681
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.